Language selection

Government of Canada

Search

2014-04-28 - Male - 7 Years old

900088935

Adverse reaction report number 900088935
Latest AER version number 1
Market authorization holder AER number CA201401404
Initial received date 2014-04-28
Latest received date 2014-05-08
Age 7 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Recovered/resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ABILIFYTABLETSuspectUnknown5 Milligram Attention deficit/hyperactivity disorder
ABILIFYTABLETSuspectUnknown5 Milligram Mental impairment
ABILIFYTABLETSuspectUnknown5 Milligram Social problem
ADDERALL XRSuspectUnknown Attention deficit/hyperactivity disorder
ADDERALL XRSuspectUnknown Mental impairment
ADDERALL XRSuspectUnknown Social problem
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral25 Milligram Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral25 Milligram Mental impairment
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral25 Milligram Social problem
INTUNIV XRTABLET (EXTENDED-RELEASE)SuspectOral1 Milligram Aggression

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Formication8 Day(s)
Pruritus8 Day(s)
Scratch
Date modified: